Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tudor-interacting repair regulator protein (TIRR, also known as NUDT16L1 or Syndesmos) is a nuclear protein that binds small nucleolar RNA and is a critical regulator of the DNA double-strand break repair pathway. It functions by binding to TP53BP1 (53BP1), masking its Tudor domain and limiting its recruitment to chromatin in the absence of DNA damage. Upon DNA damage, dissociation of TIRR from TP53BP1 unmasks this domain, enabling TP53BP1 participation in DNA repair. TIRR is also involved in RNA binding and has been implicated in the regulation of snoRNA and primary cilia formation. Mutations or misregulation of this protein have been associated with testicular yolk sac tumors and encephalitozoonosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tudor-interacting repair regulator protein (TIRR).